{"id":36082,"date":"2025-10-27T09:41:34","date_gmt":"2025-10-27T08:41:34","guid":{"rendered":"https:\/\/ggba.swiss\/adaptyv-raises-usd-8-million-to-accelerate-ai-powered-protein-validation\/"},"modified":"2025-10-27T09:50:22","modified_gmt":"2025-10-27T08:50:22","slug":"adaptyv-leve-usd-8-millions-pour-accelerer-la-validation-de-proteines-generees-par-lia","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/adaptyv-leve-usd-8-millions-pour-accelerer-la-validation-de-proteines-generees-par-lia\/","title":{"rendered":"Adaptyv l\u00e8ve USD 8 millions pour acc\u00e9l\u00e9rer la validation de prot\u00e9ines g\u00e9n\u00e9r\u00e9es par l\u2019IA"},"content":{"rendered":"\n<p>Bas\u00e9e \u00e0 \u00c9palinges sur le campus <a href=\"https:\/\/www.biopole.ch\/\">Biop\u00f4le<\/a>, la start-up <a href=\"https:\/\/www.adaptyvbio.com\/\">Adaptyv Biosystems<\/a> a lev\u00e9 USD 8 millions (CHF 6,4 millions) dans le cadre d\u2019un financement d\u2019amor\u00e7age destin\u00e9 \u00e0 d\u00e9velopper son laboratoire automatis\u00e9 dans le cloud pour la validation exp\u00e9rimentale de prot\u00e9ines con\u00e7ues par intelligence artificielle. Le tour de table a \u00e9t\u00e9 men\u00e9 par <a href=\"http:\/\/aceventures.vc\/\">ACE Ventures<\/a>, avec la participation de <a href=\"http:\/\/byfounders.vc\/\">ByFounders<\/a>, <a href=\"http:\/\/founderful.com\/\">Founderful<\/a>, <a href=\"http:\/\/longgame.vc\/\">LongGame Ventures<\/a> et plusieurs investisseurs individuels.<\/p>\n\n\n\n<p>Fond\u00e9e par Julian Englert (CEO) et Daniel Nakhaee-Zadeh (CTO), Adaptyv s\u2019attaque \u00e0 l\u2019un des principaux goulets d\u2019\u00e9tranglement de l\u2019ing\u00e9nierie prot\u00e9ique moderne : la validation exp\u00e9rimentale. Si l\u2019intelligence artificielle peut g\u00e9n\u00e9rer des milliers de structures prot\u00e9iques potentielles en silico, v\u00e9rifier leurs performances en laboratoire demeure un processus lent, co\u00fbteux et complexe.<\/p>\n\n\n\n<p>La solution d\u2019Adaptyv automatise l\u2019ensemble du cycle \u00ab design\u2013test\u2013learn \u00bb, en connectant directement les mod\u00e8les d\u2019IA aux donn\u00e9es exp\u00e9rimentales. Gr\u00e2ce \u00e0 son laboratoire accessible dans le cloud, les chercheurs peuvent t\u00e9l\u00e9charger leurs mod\u00e8les de prot\u00e9ines, lancer des tests de validation et recevoir les r\u00e9sultats exp\u00e9rimentaux \u00e0 distance. Cette approche permet une it\u00e9ration plus rapide et plus fiable entre la conception informatique et la validation r\u00e9elle.<\/p>\n\n\n\n<p>Depuis son lancement en version b\u00eata, Adaptyv a d\u00e9j\u00e0 test\u00e9 plus de 10\u2019000 prot\u00e9ines, en collaboration avec une trentaine d\u2019\u00e9quipes issues de la pharma, des biotechs et de la recherche en IA \u00e0 travers le monde. Lors d\u2019une comp\u00e9tition internationale, le taux de r\u00e9ussite des prot\u00e9ines test\u00e9es via sa plateforme est pass\u00e9 de 2,5% \u00e0 13% en seulement deux mois, illustrant son potentiel pour acc\u00e9l\u00e9rer le d\u00e9veloppement de prot\u00e9ines th\u00e9rapeutiques et industrielles.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Quand l\u2019automatisation, la biotechnologie et le machine learning se rencontrent<\/h4>\n\n\n\n<p>Gr\u00e2ce \u00e0 ce nouveau financement, Adaptyv pr\u00e9voit d\u2019\u00e9largir les capacit\u00e9s de sa plateforme, de diversifier sa gamme d\u2019essais biochimiques, de renforcer l\u2019automatisation et de lancer une API reliant directement les mod\u00e8les d\u2019IA aux r\u00e9sultats exp\u00e9rimentaux. L\u2019objectif : rendre la validation exp\u00e9rimentale aussi \u00e9volutive que la conception de prot\u00e9ines elle-m\u00eame.<\/p>\n\n\n\n<p>\u00ab Les mod\u00e8les d\u2019IA appliqu\u00e9s \u00e0 la biologie ne valent que par la qualit\u00e9 des donn\u00e9es exp\u00e9rimentales sur lesquelles ils s\u2019appuient \u00bb, explique Julian Englert, CEO d\u2019Adaptyv. \u00ab Nous construisons le cha\u00eenon manquant entre la conception computationnelle et la validation r\u00e9elle.&nbsp;\u00bb<\/p>\n\n\n\n<p>S\u2019appuyant sur son tour de pr\u00e9-amor\u00e7age de CHF 2,5 millions lev\u00e9 en 2022, Adaptyv illustre la force de la Suisse occidentale dans l\u2019innovation en sciences de la vie pilot\u00e9e par l\u2019IA, o\u00f9 automatisation, biotechnologie et apprentissage automatique convergent pour red\u00e9finir l\u2019avenir de l\u2019ing\u00e9nierie des prot\u00e9ines.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La start-up vaudoise Adaptyv Biosystems obtient un nouveau financement et lance son laboratoire automatis\u00e9 dans le cloud pour combler le foss\u00e9 entre la conception de prot\u00e9ines par IA et leur validation exp\u00e9rimentale.<\/p>\n","protected":false},"author":6,"featured_media":36086,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1179,1238,1169,1180,1148,1188,1168],"class_list":["post-36082","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-artificial-intelligence-fr-2","tag-bioinformatics-fr-2","tag-biotech-fr-2","tag-digital-health-fr-2","tag-financing-fr-2","tag-healthcare-fr-2","tag-technology-park-fr-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Adaptyv l\u00e8ve USD 8 millions | GGBa<\/title>\n<meta name=\"description\" content=\"La start-up vaudoise Adaptyv Biosystems obtient un nouveau financement et lance son laboratoire automatis\u00e9 dans le cloud.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/adaptyv-leve-usd-8-millions-pour-accelerer-la-validation-de-proteines-generees-par-lia\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Adaptyv l\u00e8ve USD 8 millions | GGBa\" \/>\n<meta property=\"og:description\" content=\"La start-up vaudoise Adaptyv Biosystems obtient un nouveau financement et lance son laboratoire automatis\u00e9 dans le cloud.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/adaptyv-leve-usd-8-millions-pour-accelerer-la-validation-de-proteines-generees-par-lia\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-27T08:41:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-27T08:50:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Adatpyv-Bio-Logo-1180x811-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/adaptyv-leve-usd-8-millions-pour-accelerer-la-validation-de-proteines-generees-par-lia\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/adaptyv-leve-usd-8-millions-pour-accelerer-la-validation-de-proteines-generees-par-lia\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Adaptyv l\u00e8ve USD 8 millions pour acc\u00e9l\u00e9rer la validation de prot\u00e9ines g\u00e9n\u00e9r\u00e9es par l\u2019IA\",\"datePublished\":\"2025-10-27T08:41:34+00:00\",\"dateModified\":\"2025-10-27T08:50:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/adaptyv-leve-usd-8-millions-pour-accelerer-la-validation-de-proteines-generees-par-lia\/\"},\"wordCount\":486,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/adaptyv-leve-usd-8-millions-pour-accelerer-la-validation-de-proteines-generees-par-lia\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Adatpyv-Bio-Logo-1180x811-1.jpg\",\"keywords\":[\"Artificial Intelligence\",\"Bioinformatics\",\"Biotech\",\"Digital Health\",\"Financing\",\"Healthcare\",\"Technology Park\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/fr\/adaptyv-leve-usd-8-millions-pour-accelerer-la-validation-de-proteines-generees-par-lia\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/adaptyv-leve-usd-8-millions-pour-accelerer-la-validation-de-proteines-generees-par-lia\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/adaptyv-leve-usd-8-millions-pour-accelerer-la-validation-de-proteines-generees-par-lia\/\",\"name\":\"Adaptyv l\u00e8ve USD 8 millions | GGBa\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/adaptyv-leve-usd-8-millions-pour-accelerer-la-validation-de-proteines-generees-par-lia\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/adaptyv-leve-usd-8-millions-pour-accelerer-la-validation-de-proteines-generees-par-lia\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Adatpyv-Bio-Logo-1180x811-1.jpg\",\"datePublished\":\"2025-10-27T08:41:34+00:00\",\"dateModified\":\"2025-10-27T08:50:22+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"La start-up vaudoise Adaptyv Biosystems obtient un nouveau financement et lance son laboratoire automatis\u00e9 dans le cloud.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/adaptyv-leve-usd-8-millions-pour-accelerer-la-validation-de-proteines-generees-par-lia\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/adaptyv-leve-usd-8-millions-pour-accelerer-la-validation-de-proteines-generees-par-lia\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/adaptyv-leve-usd-8-millions-pour-accelerer-la-validation-de-proteines-generees-par-lia\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Adatpyv-Bio-Logo-1180x811-1.jpg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Adatpyv-Bio-Logo-1180x811-1.jpg\",\"width\":1180,\"height\":811,\"caption\":\"La start-up vaudoise Adaptyv Biosystems obtient un nouveau financement et lance son laboratoire automatis\u00e9 dans le cloud pour combler le foss\u00e9 entre la conception de prot\u00e9ines par IA et leur validation exp\u00e9rimentale.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/adaptyv-leve-usd-8-millions-pour-accelerer-la-validation-de-proteines-generees-par-lia\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Adaptyv l\u00e8ve USD 8 millions pour acc\u00e9l\u00e9rer la validation de prot\u00e9ines g\u00e9n\u00e9r\u00e9es par l\u2019IA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Adaptyv l\u00e8ve USD 8 millions | GGBa","description":"La start-up vaudoise Adaptyv Biosystems obtient un nouveau financement et lance son laboratoire automatis\u00e9 dans le cloud.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/adaptyv-leve-usd-8-millions-pour-accelerer-la-validation-de-proteines-generees-par-lia\/","og_locale":"fr_FR","og_type":"article","og_title":"Adaptyv l\u00e8ve USD 8 millions | GGBa","og_description":"La start-up vaudoise Adaptyv Biosystems obtient un nouveau financement et lance son laboratoire automatis\u00e9 dans le cloud.","og_url":"https:\/\/ggba.swiss\/fr\/adaptyv-leve-usd-8-millions-pour-accelerer-la-validation-de-proteines-generees-par-lia\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2025-10-27T08:41:34+00:00","article_modified_time":"2025-10-27T08:50:22+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Adatpyv-Bio-Logo-1180x811-1.jpg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/adaptyv-leve-usd-8-millions-pour-accelerer-la-validation-de-proteines-generees-par-lia\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/adaptyv-leve-usd-8-millions-pour-accelerer-la-validation-de-proteines-generees-par-lia\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Adaptyv l\u00e8ve USD 8 millions pour acc\u00e9l\u00e9rer la validation de prot\u00e9ines g\u00e9n\u00e9r\u00e9es par l\u2019IA","datePublished":"2025-10-27T08:41:34+00:00","dateModified":"2025-10-27T08:50:22+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/adaptyv-leve-usd-8-millions-pour-accelerer-la-validation-de-proteines-generees-par-lia\/"},"wordCount":486,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/fr\/adaptyv-leve-usd-8-millions-pour-accelerer-la-validation-de-proteines-generees-par-lia\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Adatpyv-Bio-Logo-1180x811-1.jpg","keywords":["Artificial Intelligence","Bioinformatics","Biotech","Digital Health","Financing","Healthcare","Technology Park"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/fr\/adaptyv-leve-usd-8-millions-pour-accelerer-la-validation-de-proteines-generees-par-lia\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/adaptyv-leve-usd-8-millions-pour-accelerer-la-validation-de-proteines-generees-par-lia\/","url":"https:\/\/ggba.swiss\/fr\/adaptyv-leve-usd-8-millions-pour-accelerer-la-validation-de-proteines-generees-par-lia\/","name":"Adaptyv l\u00e8ve USD 8 millions | GGBa","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/adaptyv-leve-usd-8-millions-pour-accelerer-la-validation-de-proteines-generees-par-lia\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/adaptyv-leve-usd-8-millions-pour-accelerer-la-validation-de-proteines-generees-par-lia\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Adatpyv-Bio-Logo-1180x811-1.jpg","datePublished":"2025-10-27T08:41:34+00:00","dateModified":"2025-10-27T08:50:22+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"La start-up vaudoise Adaptyv Biosystems obtient un nouveau financement et lance son laboratoire automatis\u00e9 dans le cloud.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/adaptyv-leve-usd-8-millions-pour-accelerer-la-validation-de-proteines-generees-par-lia\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/adaptyv-leve-usd-8-millions-pour-accelerer-la-validation-de-proteines-generees-par-lia\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/adaptyv-leve-usd-8-millions-pour-accelerer-la-validation-de-proteines-generees-par-lia\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Adatpyv-Bio-Logo-1180x811-1.jpg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Adatpyv-Bio-Logo-1180x811-1.jpg","width":1180,"height":811,"caption":"La start-up vaudoise Adaptyv Biosystems obtient un nouveau financement et lance son laboratoire automatis\u00e9 dans le cloud pour combler le foss\u00e9 entre la conception de prot\u00e9ines par IA et leur validation exp\u00e9rimentale."},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/adaptyv-leve-usd-8-millions-pour-accelerer-la-validation-de-proteines-generees-par-lia\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"Adaptyv l\u00e8ve USD 8 millions pour acc\u00e9l\u00e9rer la validation de prot\u00e9ines g\u00e9n\u00e9r\u00e9es par l\u2019IA"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/36082","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=36082"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/36082\/revisions"}],"predecessor-version":[{"id":36084,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/36082\/revisions\/36084"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/36086"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=36082"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=36082"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=36082"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}